Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer

Table 1 Relationship of galectin-1 and vascular endothelial growth factor expression in gastric cancer tissues

VEGF	Galectin-1		P value
	Positive (n = 138)	Negative (n = 76)
Positive (n = 116)	83	33
Negative (n = 98)	55	43	0.022

VEGF: Vascular endothelial growth factor.

Table 2 Relationship of galectin-1 and vascular endothelial growth factor expression to clinicopathological variables in gastric cancer tissues

Variable	Galectin-1		P value	VEGF		P value
	(+)	(-)		(+)	(-)
Age (yr)			0.200			0.784
≤ 60	58	39		54	48
> 60	80	37		62	50
Gender			0.308			0.583
Male	87	42		62	48
Female	51	34		54	50
Tumor size			0.026			< 0.001
< 3 cm	43	36		48	73
≥ 3 cm	95	40		68	25
Tumor location			0.004			0.287
Upper third	18	3		35	21
Middle third	60	50		44	38
Lower third	60	23		37	39
Differentiation			0.112			0.998
Well	12	14		30	25
Moderate	53	27		26	22
Poor	73	35		60	51
TNM stage			< 0.001			< 0.001
T1	3	37		25	65
T2-T4	135	39		91	33
Lymph node status			< 0.001			0.002
Positive	30	46		66	35
Negative	108	30		50	63

TNM: Tumor-node-metastasis; VEGF: Vascular endothelial growth factor.